More FDA post-market activity would cut pacemaker/defibrillator failures
This article was originally published in Clinica
Executive Summary
A leading US expert on cardiac arrhythmias has uncovered a surprising percentage of product failures among the pacemakers and implantable defibrillators sold in the US over the last five years.